Peter E. Ashman

Peter Ashman practices at ENT and Allergy Associates in New York, New York.

Peter Ashman's NPI, 1043745524, was assigned on April 21, 2017. Peter Ashman graduated from Florida International University Herbert Wertheim College of Medicine in 2017. Peter Ashman holds New York license 316283.

Peter Ashman's primary practice is ENT and Allergy Associates, at 150 E 58th St, New York, NY 10155 in New York County. The practice phone is (914) 333-5800.

Peter Ashman's primary practice is ENT and Allergy Associates in New York, New York. The medical group on file is ENT and Allergy Associates. Dmand AI also links Peter Ashman to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Peter Ashman practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Peter Ashman's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Peter Ashman is licensed in New York.

CMS data shows 3,337 Medicare services from Peter Ashman across 13 procedure codes in 2024, for 898 Medicare patients. Medicare paid $302,680 for them. Every service was in an office.

CMS counts 898 Medicare patients who saw Peter Ashman in 2024. The largest group is 75 to 84, with 407 patients. 75% of them have high cholesterol, and 63% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Peter Ashman's median patient age at 47, with 53% women.

In 2024, Peter Ashman wrote 1,439 Medicare Part D claims for 461 patients. 98% of them were for generic drugs. CMS names the drug for 1,315 of them, across 16 drugs with 11 or more claims each, at $22,315 in total drug cost. In 2023, CMS named 722 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Peter Ashman for performance year 2024, reported as part of a group. Peter Ashman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Peter Ashman as offering telehealth.

Dmand AI links 12 papers to Peter Ashman, published from 2016 to 2021. 2021 was the busiest year, with 4. The most frequent topics are Ear Diseases, Hearing Loss and Middle Ear Ventilation. Peter Ashman has published most often in Acta Otolaryngol. Peter Ashman's most frequent co-authors are Adrien A. Eshraghi, MD, Brian Eric Benson, MD and Dennis I. Bojrab, MD.

CMS Open Payments shows 45 general payments to Peter Ashman from 17 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $332.

Peter Ashman graduated from Florida International University Herbert Wertheim College of Medicine in 2017.